These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15273457)

  • 1. T wave oversensing in implantable cardioverter defibrillators.
    Hsu SS; Mohib S; Schroeder A; Deger FT
    J Interv Card Electrophysiol; 2004 Aug; 11(1):67-72. PubMed ID: 15273457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avoiding inappropriate ventricular tachycardia detection due to T-wave oversensing in an implantable cardioverter defibrillator: a novel application of the electrogram width criterion.
    Duru F; Bauersfeld U; Candinas R
    Europace; 2001 Jan; 3(1):80-4. PubMed ID: 11271957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing.
    Gilliam FR
    J Cardiovasc Electrophysiol; 2006 May; 17(5):553-6. PubMed ID: 16684033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia.
    Krishen A; Shepard RK; Leffler JA; Wood MA; Ellenbogen KA
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1701-3. PubMed ID: 11816645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inappropriate therapy due to triple counting of the ventricular electrogram in a patient with implantable cardioverter-defibrillator.
    Alasti M; Haghjoo M; Alizadeh A; Fazelifar AF; Sadr-Ameli MA
    Heart Rhythm; 2005 Nov; 2(11):1253-5. PubMed ID: 16253917
    [No Abstract]   [Full Text] [Related]  

  • 7. T wave oversensing by a cardioverter defibrillator implanted in a patient with the Brugada syndrome.
    Porres JM; Brugada J; Marco P; García F; Azcarate B
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1563-5. PubMed ID: 15546314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in amplitude of intracardiac ventricular electrogram and inappropriate therapy in patients with an implantable cardioverter defibrillator.
    Watanabe H; Chinushi M; Izumi D; Sato A; Okada S; Okamura K; Komura S; Hosaka Y; Furushima H; Washizuka T; Aizawa Y
    Int Heart J; 2006 May; 47(3):363-70. PubMed ID: 16823242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.
    Gunderson BD; Swerdlow CD; Wilcox JM; Hayman JE; Ousdigian KT; Ellenbogen KA
    Heart Rhythm; 2010 May; 7(5):626-33. PubMed ID: 20184977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using left-ventricular-only pacing to eliminate T-wave oversensing in a biventricular implantable cardiac defibrillator.
    Khoo C; Bennett M; Chakrabarti S; LeMaitre J; Tung SK
    Can J Cardiol; 2013 Feb; 29(2):254.e5-7. PubMed ID: 22902157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopotential Oversensing Is a Major Cause of Inappropriate Shock in Subcutaneous Implantable Defibrillator in Japan.
    Tsutsui K; Kato R; Asano S; Ikeda Y; Mori H; Tawara M; Tanaka S; Hasegawa S; Nakano S; Iwanaga S; Muramatsu T; Matsumoto K
    Int Heart J; 2020 Sep; 61(5):913-921. PubMed ID: 32921668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias.
    Washizuka T; Chinushi M; Tagawa M; Kasai H; Watanabe H; Hosaka Y; Yamashita F; Furushima H; Abe A; Watanabe H; Hayashi J; Aizawa Y
    Jpn Circ J; 2001 Nov; 65(11):927-30. PubMed ID: 11716240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial inhibition of ongoing antitachycardia pacing sequence due to T-wave oversensing.
    Manolis AG; Chatzis DG; Kouvelas K; Kyriakides ZS
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):780-1. PubMed ID: 18507556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of T-wave oversensing with implantable cardioverter defibrillator generator replacement in an adolescent.
    Tuzcu V
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):929-32. PubMed ID: 17584279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual mechanism causing inappropriate implantable cardioverter defibrillator shocks: transient reduction in R-wave amplitude.
    Baranchuk A; Ribas S; Divakaramenon S; Morillo CA
    Europace; 2007 Aug; 9(8):694-6. PubMed ID: 17478463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-wave oversensing and inappropriate shocks: a case report.
    Srivathsan K; Scott LR; Altemose GT
    Europace; 2008 May; 10(5):552-5. PubMed ID: 18442965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable cardioverter defibrillator replacement guided by T wave safety margin in a short QT syndrome patient.
    Shen Y; Pan W; Jiang C; Fu G; Sun Y; Hu D
    Pacing Clin Electrophysiol; 2019 May; 42(5):557-559. PubMed ID: 30548872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An "inappropriately appropriate" shock in a subcutaneous implantable cardioverter-defibrillator: The importance of the SMART pass algorithm.
    Rubio Campal JM; Benezet-Mazuecos J; Sánchez-Borque P; Blanco ÁM; Crosa J; Arias MA
    J Electrocardiol; 2018; 51(6):941-944. PubMed ID: 30497752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator.
    Alasti M; Machado C; Kotschet E; Alison J
    Heart Lung Circ; 2019 Apr; 28(4):e88-e90. PubMed ID: 30482685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.